Esperion to Participate in Upcoming 21st Annual Needham Virtual Healthcare Conference

ANN ARBOR, Mich., March 29, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that President and Chief Executive Officer, Sheldon Koenig, will present at the upcoming Needham 21st Annual Healthcare Conference on Tuesday, April 12, 2022.

Event:	21st Annual Needham Healthcare Conference
Date:	Tuesday, April 12, 2022
Format:	Virtual Fireside Chat and 1:1 Meetings
Time:	9:30 a.m. ET

Live audio webcasts of these events can be accessed on the investor relations section of the Esperion website at www.esperion.com/investors-media/events-presentations/. Replays of the webcasts will be archived on the Company's website for 90 days following the events.

Esperion Therapeutics

Esperion is The Lipid Management Company. Our goal is lipid management for everybody, that’s why we work hard to make our medicines easy to get, easy to take and easy to have. We discover, develop and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate and resourceful. For more information, please visit www.esperion.com and follow us on Twitter at www.twitter.com/EsperionInc.

Investor Contact:Ben ChurchEsperion[email protected]

Source: Esperion Therapeutics, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• TamaBio to Showcase Synthetic Biomembrane Technology at ACS Clinical Congress 2026 in Washington, D.C.
• Leo Cancer Care Brings Into Clinical Use an Upright Radiotherapy Platform Cleared for Use With Any Radiation Beam
• How Work Experience and Occupation Choice Can Shape an Australian Visa Application